ERIC CHANGEH: Open Payments
NPI 1669174397 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 11 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $411 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 4 | $141 |
| Otsuka America Pharmaceutical, Inc. | 5 | $108 |
| Neurocrine BioSciences, Inc. | 2 | $32 |
Products named: NUPLAZID, REXULTI, INGREZZA.
Industry payments across TX — which companies pay providers there.
